Unraveling and controlling late-onset neurotoxicity of antisense oligonucleotides through strategic chemical modifications
{{output}}
Antisense oligonucleotides (ASOs) represent an attractive therapeutic approach for CNS disorders. However, ASO-induced neurotoxicity, especially late-onset adverse events, remains a crucial issue, leading to failures in clinical applications. This study aims t... ...
